← Back to Clinical Trials
Recruiting NCT06579781

NCT06579781 Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06579781
Status Recruiting
Phase
Sponsor Child Trends
Condition Sexual Behavior
Study Type INTERVENTIONAL
Enrollment 2,000 participants
Start Date 2024-10-21
Primary Completion 2028-04-30

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Morehouse Family Health Study's Parent Toolkit 2.0Morehouse Family Health Study's General Health Guide

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 2,000 participants in total. It began in 2024-10-21 with a primary completion date of 2028-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Child Trends will conduct a randomized control trial evaluation of Parent Toolkit 2.0, an innovative intervention for parents and caregivers of middle and high school students. Child Trends will collaborate with Morehouse School of Medicine and Tressa Tucker \& Associates, LLC to implement and evaluate the program with 1,000 parent-teen pairs across Georgia. The program includes three components that will be delivered across a three-week period: (1) an online self-paced Parent Guide with information, tips, tools, and resources on adolescent health, including sexual health; (2) four videos modeling parent-teen communication around sex and contraception; and (3) two group-based sessions for parent participants to discuss program content and improve communication skills. The program aims to increase parent knowledge and parent-teen communication about adolescent health, sexual health, and relationships to help youth adopt health-promoting behaviors such as delaying sexual initiation and increasing contraceptive use.

Eligibility Criteria

Inclusion Criteria for Adult Participants: * 25 to 70 years old * Lives in an eligible zip code in Georgia * Parent or caregiver of 12- to 15-year-old child who wants to participate in this study with them * Lives with child at least 50% of the time Exclusion Criteria for Adult Participants: * Lives in a home with a child who is already enrolled in this study * Raises child with an adult who is already enrolled in this study Inclusion Criteria for Child Participants: * 12-15 years old * Lives with a parent or caregiver who wants to participate in this study with them * Able to complete surveys on own or with help of support person Exclusion Criteria for Child Participants: \- Does not have their own email address or phone number

Contact & Investigator

Central Contact

Asari Offiong, PhD

✉ aoffiong@childtrends.org

📞 (240) 223-9306

Principal Investigator

Jennifer Manlove, PhD

PRINCIPAL INVESTIGATOR

Child Trends

Frequently Asked Questions

Who can join the NCT06579781 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 15 Years, studying Sexual Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06579781 currently recruiting?

Yes, NCT06579781 is actively recruiting participants. Contact the research team at aoffiong@childtrends.org for enrollment information.

Where is the NCT06579781 trial being conducted?

This trial is being conducted at Cairo, United States.

Who is sponsoring the NCT06579781 clinical trial?

NCT06579781 is sponsored by Child Trends. The principal investigator is Jennifer Manlove, PhD at Child Trends. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology